MONJUVI

Indicated For

Relapsed or refractory diffuse large B-cell lymphoma (DLBCL)

About This Medication

# IncyteCARES for MONJUVI Patient Guide: How to Get MONJUVI (tafasitamab-cxix) at Low or No Cost This guide explains the **IncyteCARES for MONJUVI** program from **Incyte Corporation**, designed to help eligible patients access **MONJUVI (tafasitamab-cxix)**, a prescription medicine used with lenalidomide for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).[1][7] We'll cover who qualifies, program details, how to apply, and more in simple terms to make it easy for you to understand and take action. ## About MONJUVI (tafasitamab-cxix) **MONJUVI** is an intravenous (IV) infusion medication given by a healthcare professional. It's FDA-approved, in combination with lenalidomide (an oral capsule), to treat adults with certain types of DLBCL that has returned or not responded to prior treatments.[1][4][7] Treatment follows a cycle-based schedule: In Cycle 1 (28 days), you receive MONJUVI on 5 days; Cycles 2-3 on Days 1, 8, 15, 22; Cycles 4-12 on Days 1 and 15; and after Cycle 12, maintenance with MONJUVI on Day 1 of each 28-day cycle.[4] Your doctor will also prescribe lenalidomide for the first 12 cycles (Days 1-21 orally).[4] **Important safety notes**: MONJUVI can cause infusion-related reactions (like fever, chills, rash), myelosuppression (low blood counts), infections, and embryo-fetal toxicity—use effective birth control during treatment and for 3 months after.[3][5][7] Always discuss risks with your doctor, monitor blood counts, and follow premedication instructions.[3][5] The IncyteCARES program helps with medication costs but **does not cover administration fees** (like IV infusion costs).[1][8] An **annual benefit maximum** and other restrictions apply; terms can change.[1][8] ## Who Qualifies for IncyteCARES for MONJUVI? To join, you must: - Be a resident of the United States or Puerto Rico.[1][8] - Have a **valid prescription** for MONJUVI for an FDA-approved use (or compendia-recognized use).[1][8] - Be enrolled in the program after assessment.[1][2] **Key eligibility criteria** focus on insurance and income (for uninsured): The program supports patients with commercial insurance via savings cards or assistance. However, it explicitly excludes Medicare Part B, Medicare Advantage, Medicaid, TRICARE, state assistance programs, or uninsured patients without meeting income criteria.[Program details] **Insurance Requirements**: - **Must have commercial healthcare coverage** (private insurance).[Program details][1] - **Not eligible if**: - Enrolled in Medicare Part B or Medicare Advantage. - On Medicaid. - Covered by TRICARE. - Using state medical/pharmaceutical assistance. - Uninsured (unless meeting specific uninsured income criteria, details via phone).[Program details][1][8] Once enrolled, an IncyteCARES representative calls to review your coverage, assess savings/financial aid eligibility (*terms apply*), and explain support.[1][2][8] ## Income Eligibility Breakdown Specific household income thresholds are not publicly listed online (null in program data), so **call (855) 452-5234** for your personalized assessment.[Program details] Uninsured patients may qualify if they meet income criteria, but commercial insurance is primary.[1][8] Here's a general overview based on similar programs (confirm yours by phone): | Household Size | Estimated Max Income (400% FPL example)* | Notes | |---------------|-----------------------------------------|-------| | 1 | ~$60,000 | Uninsured only; varies. Call for exact. | | 2 | ~$81,000 | *Illustrative; not official. | | 3 | ~$102,000 | Terms change; annual max applies. | | 4 | ~$123,000 | Add ~$21,000 per extra member. | *Federal Poverty Level (FPL) example; actual thresholds determined by IncyteCARES. Commercial insured patients often have different co-pay aid.[1][8][Program details] ## Step-by-Step Application Process Applications start **by phone**—no online form listed.[Program details] 1. **Get your prescription**: Ask your doctor for a valid MONJUVI prescription for FDA-approved use.[Program details][1] 2. **Call IncyteCARES**: Dial **(855) 452-5234** (Mon-Fri, 8 AM–8 PM ET).[2][Program details] HCPs can download/fax an enrollment form (takes ~15 min).[1] 3. **Enrollment call**: Rep welcomes you, reviews insurance, assesses eligibility for savings/assistance, and explains support.[1][2] 4. **Submit documents**: Provide proof of prescription and insurance details. **Required**: Valid MONJUVI prescription.[Program details] Additional docs (income proof for uninsured) as requested. 5. **Approval & benefits**: If eligible, get savings card or aid for med costs (exclusions apply).[1][8] HCPs often initiate enrollment for speed.[1] ## Timeline and Delivery **Processing time**: Not specified—call for estimate. Enrollment form fax takes ~15 min to complete.[1][Program details] **Delivery**: Medication ships to your doctor's office or infusion center; administered IV there. Program covers med cost only.[1][4][Program details] IncyteCARES provides ongoing support calls.[2] **Refills/reauthorization**: Not detailed; likely required periodically—call for ongoing eligibility.[Program details] ## Alternatives if Denied or Ineligible - **Appeal**: Ask why denied and resubmit docs.[General knowledge] - **Other aid**: Check state programs (if not excluded), non-profits like PAN Foundation, or NeedyMeds.org. - **Biosimilars**: None listed for MONJUVI.[Program details] - **HCP help**: Doctor can explore buy-and-bill, samples, or 340B clinics. - **Contact IncyteCARES** for guidance: (855) 452-5234.[2] ## Disclaimer This guide is for informational purposes based on available data as of program details. **IncyteCARES terms can change** (last update May 1, 2024).[1][8] Eligibility not guaranteed. **Consult your doctor** for medical advice; call **(855) 452-5234** for official details. Program covers medication only, not administration/doctor fees. See full Prescribing Info for MONJUVI risks.[7] Word count: 1028.

Program information last verified: March 30, 2026